Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Orchestra BioMed Holdings, Inc. develops innovative medical devices and bioelectronic therapies targeting large markets such as hypertension and artery disease. Its core products include AVIM therapy, a device-based hypertension treatment integrated into pacemakers, and Virtue SAB, a drug/device combo for artery disease. The company partners with industry leaders like Medtronic and Terumo to accelerate product development, commercialization, and global market access.
This description was generated via AI from an annual report. Updated about 1 year ago.